Related Experiment Video
Updated: Dec 29, 2025
14:16
Fluorescence detection methods for microfluidic droplet platforms
Published on: December 10, 2011
22.7K
Microfluidic tools for probing micro-culprits: Opportunities and challenges in microfluidic diagnostics.
Su Bin Lim1,2, Nishanth Venugopal Menon2, Chwee Teck Lim2,3,4
1NUS Graduate School for Integrative Sciences & Engineering, National University of Singapore, Singapore, Singapore.
EMBO Reports
|January 31, 2020
Summary
Microfluidics shows great promise for cancer diagnosis. Embracing this technology requires a shift in thinking among engineers, clinicians, and regulators to realize its full potential.
Area of Science:
- Biomedical Engineering
- Oncology
- Diagnostic Technology
Background:
- Microfluidics offers advanced capabilities for biological sample manipulation and analysis.
- Early cancer detection is crucial for improving patient outcomes and treatment efficacy.
Purpose of the Study:
- To highlight the potential of microfluidic devices in revolutionizing cancer diagnostics.
- To identify barriers hindering the widespread adoption of microfluidics in clinical settings.
Main Methods:
- Review of current microfluidic applications in cancer research and diagnostics.
- Analysis of challenges related to technology integration, clinical validation, and regulatory pathways.
Main Results:
- Microfluidics enables high-throughput screening, precise biomarker detection, and minimal sample volume requirements.
- Significant hurdles exist in interdisciplinary collaboration and regulatory acceptance.
Conclusions:
- Microfluidic technology holds immense promise for transforming cancer diagnosis.
- A collaborative approach and adaptive regulatory frameworks are essential for successful implementation.
